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Abstract
Background: Dystonia constitutes a heterogeneous group of movement abnormalities, characterized by sustained or intermittent muscle contractions causing
abnormal postures. Overwhelming data suggest involvement of basal ganglia and dopaminergic pathways in dystonia. In this review, we critically evaluate recent
neuroimaging studies that investigate dopamine receptors, endogenous dopamine release, morphology of striatum, and structural or functional connectivity in
cortico-basal ganglia-thalamo-cortical and related cerebellar circuits in dystonia.
Method: A PubMed search was conducted in August 2014.
Results: Positron emission tomography (PET) imaging offers strong evidence for altered D2/D3 receptor binding and dopaminergic release in many forms of
idiopathic dystonia. Functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI) data reveal likely involvement of related cerebello-thalamo-
cortical and sensory-motor networks in addition to basal ganglia.
Discussion: PET imaging of dopamine receptors or transmitter release remains an effective means to investigate dopaminergic pathways, yet may miss factors
affecting dopamine homeostasis and related subcellular signaling cascades that could alter the function of these pathways. fMRI and DTI methods may reveal
functional or anatomical changes associated with dysfunction of dopamine-mediated pathways. Each of these methods can be used to monitor target engagement for
potential new treatments. PET imaging of striatal phosphodiesterase and development of new selective PET radiotracers for dopamine D3-specific receptors and
Mechanistic target of rampamycin (mTOR) are crucial to further investigate dopaminergic pathways. A multimodal approach may have the greatest potential, using
PET to identify the sites of molecular pathology and magnetic resonance methods to determine their downstream effects.
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Introduction
Dystonia is the third most prevalent movement disorder and afflicts
about 250,000 people in the United States.1 It comprises a highly
heterogeneous group of movement abnormalities, characterized by
sustained or intermittent muscle contractions causing abnormal,
repetitive movements and postures, or both.2 Symptoms can develop
in children or adults. They can affect a single body part, multiple
segments or be generalized. This phenotypical heterogeneity may or
may not reflect diverse etiology. Indeed, well-defined monogenic
hereditary dystonias have variable age of onset, affected body parts,
and rate of progression.3 A new categorization of dystonia distin-
guishes those with only dystonia as isolated dystonia. This review
focuses primarily on those with isolated dystonia that is either caused
by a known genetic mutation or is idiopathic (formerly called primary
dystonias).2 Poor understanding of underlying pathophysiology,
inadequate animal models and absence of biomarkers have limited
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development of adequate therapeutics for isolated idiopathic or genetic
dystonias.
Historically dystonia has been considered a basal ganglia disorder,
with numerous lines of evidence suggesting involvement of the
dopaminergic system. However, dysfunction of other brain regions
and circuits has become increasingly evident. Focal dystonias have been
associated with impaired inhibition in the somatosensory cortex and
abnormal sensorimotor processing beyond those parts of the brain that
represent the symptomatic body part.4–8 Structural and functional
imaging studies show dysfunction of the cerebellum or defects in its
connections in isolated idiopathic dystonias.9–15 Indeed, most research-
ers agree that dystonia is associated with physiologic abnormalities at
multiple levels involving cortico-ponto-cerebello-thalamo-cortical and
cortico-basal ganglia-thalamo-cortical pathways.16–18 Nevertheless,
emerging evidence indicates TOR1A, GNAL and ANO3 mutations
produce functional changes that converge to affect striatal signal
transduction pathways.19–21 Such findings underscore possible com-
monalities across at least some of these heterogeneous conditions.
Neuroimaging offers a non-invasive method to examine structural
and functional changes in humans. Initially, molecular imaging studies
of dopaminergic pathways relied on 6-fluorodopa ([18F]FD), reflecting
decarboxylase activity and storage, and non-selective dopamine D2-like
receptor radioligands such as [18F]spiperone, [11C]raclopride, and
[123I]iodobenzamide. Major advances in molecular imaging, with
development of more specific radioligands along with sophisticated
analysis methods, permit greater in-depth study of dopaminergic
pathways. Similarly, positron emission tomography (PET) and func-
tional magnetic resonance imaging (fMRI)-based blood oxygen level-
dependent (BOLD) measures have been used to investigate task-related
activation of dopaminergic pathways. Resting state fMRI (rs-fMRI) and
diffusion tensor imaging (DTI) studies assess functional and structural
connectivity of cortico-basal ganglia-thalamo-cortical circuits. Stronger
magnets (3 T and higher) and more advanced data analyses have
strengthened these studies. Admittedly, each of these methods provides
only a limited indirect view of dopaminergic pathways. In this review,
we critically evaluate recent neuroimaging studies that shed light on the
involvement of dopaminergic pathways by investigating dopamine
receptors, endogenous dopamine release, morphology of striatum and
downstream targets, and structural or functional connectivity in cortico-
basal ganglia-thalamo-cortical and related cerebellar circuits.
Methods
A PubMed search in August 2014 with keyword combinations
dystonia, PET, dopamine; dystonia MRI, dopamine; and dystonia,
SPECT, dopamine yielded 141, eight, and 58 entries, respectively. We
considered only studies pertaining to the dopaminergic system or
relevant pathways in idiopathic or hereditary dystonias.
Dopaminergic pathways
A model of basal ganglia circuitry includes cortical-striato-pallido-
thalamic-cortical loops with primary input into striatum (putamen and
caudate) from cortical glutamatergic, thalamostriatal glutamatergic,
and nigral dopaminergic projections.22–24 Two major pathways lead
from the striatum to the main output nucleus in the basal ganglia
internal segment of the pallidum (GPi) and substantia nigra pars
reticulate (SNpr): 1) the direct pathway via inhibitory GABAergic
fibers, and 2) the indirect pathway, including inhibitory GABAergic
neurons to GPe (external segment of GP), inhibitory neurons
projecting from GPe to subthalamic nucleus (STN), and excitatory
glutamatergic neurons projecting from STN to GPi/SNr. GPi/SNr
send inhibitory GABAergic neurons to the ventral anterior thalamus
that project via excitatory neurons to cortical areas, including the
premotor and motor regions. Multiple studies suggest that the direct
pathway selects the desired movement (facilitation), while the indirect
pathway suppresses unwanted surrounding movement (inhibition).25
Dystonia could represent a defect in surround inhibition (abnormal
function of the indirect pathway) perhaps coupled with excessive
facilitation of the intended movement (overactivation of the direct
pathway).26
Dopaminergic nigrostriatal input regulates the activity in direct and
indirect pathways. Indeed, the nigrostriatal dopaminergic fibers
terminate on the shafts of the dendritic spines of the medium spiny
neurons (MSNs)27 and the cortical afferents terminate on the heads of
spines, enabling dopamine modulation of the corticostriatal input.
Dopamine receptors are G-coupled proteins that divide into D1-like and
D2-like families. D1-like (D1, D5) receptors activate and D2-like (D2,
D3, D4) receptors inhibit adenylate cyclase.28,29 Phosphodiesterases are
highly expressed in the striatum and control this signaling cascade by
regulating the level of cyclic adenosine monophosphate (cAMP).30
Excitatory D1-like receptors are located exclusively post-synaptically on
medium spiny neurons that project to the Gpi/SNpr (direct pathway),
while inhibitory D2 receptors (D2R) are located post-synaptically on
neurons that project to GPe (indirect pathway). This concept is
supported by measurements of D1 receptor (D1R) and D2R mRNA31
and transgenic mice models with near-complete segregation of D1R and
D2R expression.32,33 D3 receptors (D3R) are expressed in striatum as
well. Most data suggest that D3R is predominantly in ventral (limbic)
and to a far lesser degree in dorsal (motor) striatum. However, recent
autoradiographic studies with a highly D3-selective radioligand have
demonstrated a substantial amount of D3R in human dorsal striatum.34
A small subpopulation of striatal MSN contains both D1R and D2-like
receptors,35,36 and emerging evidence indicates that D1R and D3R can
form heterodimers capable of enhancing D1R-mediated activity.37,38
Nigrostriatal fibers express presynaptic D2R and D3R (autoreceptors) as
well, which are inhibitory and their activation reduces the dopamine
release at the synaptic cleft between nigrostriatal fibers and medium
spiny neurons.
Molecular imaging and dopamine receptors
Many observations suggest that dysfunction of D2-like receptors
underlies the pathophysiology of idiopathic and some acquired forms of
dystonia. Exposure to drugs that block D2-like receptors can cause acute
dystonia.39–41 Non-human primates treated with intracartoid MPTP
(1-methyl-4-phenyl-1,2 3,6-tetrahydropyridine) develop transient dystonia.
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The dystonic phase corresponds with a decrease in D2-like striatal
receptors as measured ex vivo in striatal brain tissue. MPTP selectively
destroys dopaminergic neurons, possibly reducing dopamine autorecep-
tors. The transient nature of this drop in D2-like receptors could either
indicate reconstitution of these neurons, which did not occur, or that the
D2-like effect was not due to a change in autoreceptors but rather a
transient change in post-synaptic receptors.42 Numerous molecular
imaging studies with PET or single-photon emission computed tomo-
graphy (SPECT) with D2-like radioligands report decreased striatal uptake
in various forms of isolated idiopathic dystonias. These include isolated
idiopathic hand dystonia, cranial dystonia,43–45 and cervical dystonia46 as
well as the inherited dystonias caused by mutations in TOR1A/DYT1,47
THAP1/DYT6,48 and e-sarcoglycan/DYT11.49 However, almost all D2-
like radioligands have numerous limitations. They do not distinguish
between pre- and post-synaptic dopaminergic receptors and can be
displaced by endogenous dopamine. We found reduced striatal
[18F]spiperone binding in idiopathic focal dystonia,44 but this non-specific
radioligand also binds to 5-hydroxytryptamine (5-HT) (2A) receptors in
primate striatum.50 Other studies report reduced striatal [11C]raclopride
uptake, which has a low selectivity for 5-HT(2A) but near equal selectivity
for D2R and D3R48,51 and can be displaced by endogenous dopamine.52
Such displacement can confound interpretation of reduced raclopride
uptake, which can indicate either reduced D2-like binding sites or
increased competition with elevated striatal dopamine. However,
subsequent studies with the highly selective D2R radioligand N-methyl-
benperidol (NMB) did not identify reduced striatal uptake in isolated
idiopathic hand or cranial dystonia. Since NMB is 200-fold more selective
for D2R than D3R and is not displaced by endogenous dopamine, these
findings suggest that previously reported reduced striatal D2-like binding
may reflect a reduction in striatal D3R rather than a change in D2R.53
D3R could play a role in pathophysiology of dystonia through presynaptic
autoregulatory receptor sites, a regulatory effect on dopamine transporter,
or interaction with D1-like receptors.54–56 Proof of this hypothesis requires
PET studies with D3R-selective radioligands. Such radioligands have been
developed and successfully used in non-human primate studies51 but no
studies in humans have yet been reported.
Alternatively, if changes in endogenous dopamine affect dopamine-
selective radioligands, an alteration of striatal dopamine concentration
could explain apparent differences in striatal radioligand uptake.
Reports of post-mortem striatal dopamine levels reveal contradictory
results.57,58 Voxel-wise analysis of task-induced striatal dopamine
release revealed decreased [11C]raclopride displacement with a motor
task involving the affected body part in patients with laryngeal dystonia
compared with healthy controls. In contrast, a motor task of an
uninvolved body part elicited an increased striatal [11C]raclopride
displacement in the same patients compared with healthy controls.59
These findings suggest altered striatal dopamine release compared with
healthy controls. An analogous study in patients with writer’s cramp
(another isolated idiopathic dystonia) yielded similar findings, con-
firming common dopaminergic pathway changes across these two
focal isolated idiopathic dystonia subtypes.59,60 It remains to be
determined whether this occurs in other forms of isolated idiopathic
dystonia. These studies further suggest somatotopical reduction of
striatal dopamine release, as long as the clusters of reduced dopamine
release associated with different affected body parts were distinct from
each other without any overlap. Interestingly, a [18F]spiperone PET
study revealed that changes in striatal D2-like receptors may be
somatotopically organized in hand and cranial dystonias.61
D1-like receptors primarily influence the direct pathway.62 Resting
metabolic PET studies showing overactivity in the putamen and globus
pallidus have been used to support the idea that dystonia may be
associated with increased activity in the direct pathway causing
excessive disinhibition of motor cortical areas. However, PET studies
with [11C]NNC-112, a selective D1-like ligand without displacement
by internal dopamine, did not reveal a significant alteration in striatal
binding in dopa-responsive dystonia (DRD),63 or isolated idiopathic
focal dystonia (cranial, cervical, arm).64 Certainly, these findings do
not exclude involvement of the direct pathway mediated by changes
other than in D1-like receptors.
Molecular imaging and dopaminergic presynaptic integrity
[11C]DTBZ (dihydrotetrabenazine; reflecting vesicular monoamine
transporter type 2 [VMAT2]), [11C]MP (methyl-phenidate or other
similar radioligands; reflecting dopamine membranous transporter
[DAT]) and [18F]FD ([6-fluorodopa; reflecting primarily dopa
decarboxylase activity and trapping) provide insight into nigrostriatal
fiber and nigral cell integrity (Figure 1).65 Striatal [11C]DTBZ uptake
was increased in L-dopa naive dopa-responsive dystonia (DRD) while
[11C]MP and [18F]FD uptake were unchanged, suggesting likely
compensatory increased neuronal firing or decreased dopamine
competition for VMAT2 binding sites or a combination of both in
DRD.66 This finding was consistent with a SPECT study revealing
normal (99m)Tc-TRODAT-1 uptake as a measure of DAT in DRD.67
Other dystonia types in particular isolated idiopathic focal dystonias
have not been examined with these ligands.
Figure 1. Binding Sites of Relevant Radiotracers at a Dopaminergic Synapse.
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Functional imaging and dopamine pathways
Neuroimaging of dopaminergic receptors or dopamine release only
provides a limited view of dopaminergic pathways. The downstream
functional consequences of such defects may be identified with indirect
measures of neuronal functions. This may be achieved with PET or
fMRI during task- or drug-induced activation or at rest. Similarly,
structural imaging may identify changes in pathways related to
dopaminergic systems.
Task-related imaging
Task-related changes in regional brain activity can be used to map
brain responses and interrogate relevant brain pathways.
[18F]Fludeoxyglucose (FDG) and [15O]H2O PET studies measure
glucose metabolism and regional cerebral blood flow (rCBF),
respectively, while fMRI BOLD signals relate to hemodynamic
responses that change blood oxygen content. These measures
represent a surrogate for increased interneuronal synaptic activity
and changes in input to the region.68,69 Numerous task-related PET
and fMRIs have been completed in people with various types of
dystonia.70 Inconsistent findings in basal ganglia, sensorimotor cortex,
and cerebellum across many of these studies likely reflect variations in
the choice of task, differences in task performance, and presence of
dystonia.71–73 Sensory tasks may or may not have this same confound
depending upon whether the sensory task elicits any motor responses.
Several studies of vibration-induced brain responses revealed reduced
rCBF responses74,75 that may be influenced by dopaminergic
pathways.76
Resting state imaging
Similar to task-related imaging, resting state studies can be
performed with PET measures of metabolism and blood flow, or with
MRI measures of BOLD signals. Resting state studies minimize
confounds related to differences in task execution during scanning,
which is a major advantage compared with task-related imaging.
Many PET FDG studies have revealed involvement of dopaminergic
pathways. Galardi et al.77 demonstrated hypermetabolism in the basal
ganglia, thalamus, premotor–motor cortex, and cerebellum in the
isolated idiopathic cervical dystonia compared with healthy controls.
However, an FDG study of a group including generalized dystonia,
hemidystonia, and focal dystonias revealed decreased activity in
striatum and globus pallidus.78 Inclusion of hemidystonia, which is
commonly an acquired dystonia, clearly confounds interpretation of
these findings. Eidelberg and colleagues79–82 have applied a principal
components analysis method to identify changes in spatial covariance
patterns in FDG uptake to define metabolic networks associated with
dystonia, and identified increased contributions from posterior puta-
men, globus pallidus, cerebellum, and SMA (supplemental motor area)
in patients with blepharospasm and in DYT1 and DYT6 carriers,
regardless of the presence of clinical manifestation. A direct
comparison of regional glucose metabolism revealed genotype-related
metabolic changes including hypermetabolism in the putamen,
anterior cingulate, and cerebellum of DYT1 carriers, and hypometa-
bolism in the putamen and temporal cortex of DYT6 carriers.83
Remarkably, the phenotype-related activity pattern in the same study
did not include dopaminergic pathways.
rs-fMRI correlations are based on intrinsic fluctuations in the
BOLD signal that reflects slow variations in neuronal activity
propagating through connected networks. Changes in these fluctua-
tions indicate network dysfunction.84 Most rs-fMRI studies in isolated
idiopathic focal dystonias indicate reduced connectivity in putamen
and sensorimotor network regardless of the affected body part
(Table 1).85–89 However, a recent study in focal hand dystonia with
extensive cortical, subcortical, and cerebellar seeds did not show any
difference in putamenal functional connectivity but instead found
changes in functional connectivity of the globus pallidus and
cerebellum.90 While most research has focused on investigating the
correlations between low-frequency fluctuations, Zhou et al.91
analyzed the amplitude of these fluctuations, which revealed increased
amplitude in the putamen and globus pallidus and decreased
amplitude in the somatosensory region, thalamus, and cerebellum.
Overall, these rs-fMRI studies were conducted following various
protocols with different levels of quality assurance. Multiple compar-
ison and head motion correction are two major concerns in rs-fMRI
analyses. Most studies apply a family-wise error rate to correct for
multiple comparisons at the subject level, but only a few perform a
Bonferroni correction, which is a far more stringent correction at the
group level analysis. Some studies do not apply any correction, or
apply only small-volume correction for a priori regions (Table 1). It is
not surprising that such a heterogeneous level of control over false
discovery can contribute to variable and difficult to reproduce data.
Motion-induced signal change is another major challenge in analyzing
rs-fMRI data, as it causes spurious misleading correlations.92 Most
recent studies try to address this issue by censoring frames with
excessive movement and regressing various parameters such as the
global signal, or cerebrospinal fluid and white matter signal, in
addition to motion parameters. Indeed in many cases excessive frame
censoring could lead to exclusion of the subject from data analysis.93
However, many dystonia studies do not comment on motion
correction measures. Interestingly, no study mentions exclusion of
subjects due to excessive frame-to-frame movement.84–90,94
Application of improved analysis and motion correction methods
may enhance the quality and reproducibility of findings and reveal
new insights into functional consequences of altered dopaminergic
pathways as shown in idiopathic Parkinson disease.93
Structural imaging and dopamine pathways
Numerous earlier reports showed striatal abnormalities in CT scans of
idiopathic or secondary dystonias.95–98 With advances in MRI, many
studies have measured the gray matter volume of relevant structures
such as the caudate and putamen, thalamus and sensorimotor cortex in
different dystonia subtypes. Nonetheless, the patient population,
number of participants, strength of the magnetic field, data acquisition
and the processing method have been highly variable among these
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studies, which could explain the inconsistent findings. In fact,
some showed increased, decreased, or no change in putamenal
volume.60,99,100 Improved magnetization-prepared rapid gradient-echo
(MPRAGE) contrast and stronger magnetic fields may improve the
reliability of volumetric measurements in future studies.
Diffusion tensor imaging
Another commonly used structural neuroimaging modality is DTI.
It is based on diffusion of water molecules in the tissue and provides
information about cellularity and integrity of aligned axons. Fractional
anisotropy describes the degree of restriction in water molecule
diffusion,101 such that a higher value is associated with aligned axons.
Mean diffusivity corresponds to diffusion of water molecules and has
higher values as the cellularity of the tissue declines.102 In particular,
diffusion tensor tractography permits in vivo mapping of structural
connectivity, where white matter fiber trajectories are reconstructed by
tracking the direction of fastest diffusion between two targets.
Similar to rs-fMRI, early DTI studies in dystonia show highly
inconsistent findings, usually including some elements of the basal
ganglia, cerebellum, and sensorimotor cortex.103 DTI findings depend
upon the investigated brain regions of interest (ROI). Many early DTI
studies did not include measures of basal ganglia connections.
Furthermore, most of these early DTI studies employed magnetic
resonance scanners with relatively low field strength of 1.5 T.
Fractional anisotropy and mean diffusivity measures vary significantly
between 3 T and 1.5 T magnets.104,105 A stronger magnetic field
presumably improves the signal-to-noise ratio at the cost of greater
distortion, which must be addressed. Field map corrections attempt to
compensate for low distortions, but such corrections have not yet been
applied to most studies.106 In addition, only a few studies have
implemented diffusion tensor tractography to determine structural
connectivity. Recent DTI studies have defined microstructural changes
such as subgyral white matter abnormalities of the sensorimotor cortex
and cerebello-thalamic tracts associated with genotype in both
manifesting and non-manifesting DYT1 and DYT6 carriers.107,108
They have further identified somatotopic white matter changes109 and
thalamocortical tract abnormalities110 related to clinical phenotype.
However, none of these studies included basal ganglia as ROI for the
tractography analysis, hence diffusion tensor tractography measures of
dopaminergic pathways remain to be determined in future studies.
Conclusion
Although specific genetic defects may cause some forms of dystonia,
in most cases its etiology remains unknown and treatment options
unsatisfactory. Neuroimaging can provide a valuable tool to investigate
the pathophysiology of dystonias. Overwhelming functional and
structural data suggest the involvement of basal ganglia and related
networks in various dystonia types. Increasing evidence also suggests
dysfunction of cerebellar pathways as a likely cause of dystonia. In fact,
a variety of anatomical and functional studies now suggest that
cerebellar and basal ganglia pathways are tightly interrelated.111 Thus,
dysfunction of dopaminergic pathways in basal ganglia could alter
cerebellar circuits and vice versa.93
Molecular imaging remains an effective neuroimaging modality to
investigate dopaminergic pathway involvement. PET imaging offers
strong evidence for altered D2/D3 receptor binding yet may miss
factors affecting dopamine homeostasis and the dopamine-related
subcellular signaling cascade, which also could alter function of these
pathways. The effect of dopamine is largely mediated through the
cyclic adenosine monophosphate/protein kinase A (cAMP/PKA)
signaling cascade and therefore controlled by phosphodiesterases
(PDEs). Different PDE isoforms are expressed in striatal dopaminergic
terminals, and the medium spiny neurons of direct and indirect
pathways. Indeed animal data suggest that PDE10 inhibitors activate
an indirect pathway.112 Novel PET radioligands are available for in vivo
human PET studies of PDE10A and should be employed in dystonia
research.113 Further, striatal specific protein Rhes can activate striatal
mTOR signaling, which is downstream of the GNAL dystonia gene.
Rhes and mTOR are modulated by dopaminergic pathways and
mediate striatal plasticity and could play a role in dystonia.20 Currently
no PET ligands are available for in vivo evaluation of these targets.
Functional or structural imaging in isolation cannot discern whether
altered basal ganglia network connections are causative, epiphenome-
non, or compensatory. However, such studies could help identify
network patterns suggestive of disease susceptibility, independent of
disease manifestation, and serve as subclinical markers of gene
expression. Alternatively, they can be used for monitoring target
engagement for disease-modifying therapies if the network pattern
correlates closely with the phenotype. In addition, functional and
structural neuroimaging data can guide histopathological studies.
Finally, combining structural and functional imaging with PET will
potentiate their effectiveness. Any region with abnormal radioligand
binding could serve as the ROI for rs-fMRI and diffusion tensor
tractography and provide information on downstream effects of the
molecular change.
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